14
Views
7
CrossRef citations to date
0
Altmetric
Invited Papers

Optimal Medical Therapy During Carotid Endarterectomy: A Personal View

Pages 285-291 | Published online: 11 Mar 2016

References

  • NICE Technology Appraisal Guidance 90 Vascular disease-Clopidogrel and dipyridamole: Quick reference guide. 25th May 2005.
  • Barnett H. J. M., Taylor D. W., Eliasziw M. et al. on behalf of the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. NEJM, 1998, 339: 1415–1425.
  • Taylor D. W., Barnett H. J. M., Haynes G. G. et al. Low dose and high dose salicylic acid for patients undergoing carotid endarterec-tomy: A randomised trial. Lancet, 1999, 353: 2179–2184.
  • Payne D. A., Hayes P. D., Jones C. I., Belham P., Naylor A. R., Bell P. R. F., Goodall A. H. Combined effects of aspirin and Clopidogrel on platelet function in-vivo and in-vitro: Implications for use in open vascular surgery. J Vasc Surg, 2002, 35: 1204–9.
  • Chassot P. G., Delabays A., Spahn D. R. Peri-operative antiplatelet therapy: The case for continuing therapy in patients at risk of myocardial infarction. Brit J Anaesth, 2007, 99: 316–328.
  • Lennard N., Smith J. L., Gaunt M. E., Abbott R., London N. J. M., Bell P. R. F., Naylor A. R. A policy of quality control assessment reduces the risk of intra-operative stroke during carotid endarterectomy. Eur J Vasc Endovasc Surg, 1999, 17: 234–240.
  • Naylor A. R., Hayes P. D., Allroggen H., Lennard N., Gaunt M. E., Thompson M. M., London N. J. M., Bell P. R. F. Reducing the risk of carotid surgery: A seven year audit of the role of monitoring and quality control assessment. J Vasc Surg, 2000, 32: 750–759.
  • Gaunt M. E., Smith J. L., Martin P. J., Ratliff D. A., Bell P. R. F., Naylor A. R. A comparison of quality control methods applied to carotid endarterectomy. Eur JVasc Endovasc Surg, 1996, 11: 4–11.
  • Lennard N., Smith J. L., Hayes P., Abbott R. J., London N. J. M., Bell P. R. F., Naylor A. R. Transcranial Dopper directed Dextran therapy in the prevention of post-operative carotid artery thrombosis: 3 hrs monitoring is as effective as 6 hrs. Eur J Vasc Endovasc Surg, 1999, 17: 301–305.
  • Hayes P. D., Box H., Tull S., Gaunt M. E., Bell P. R. F., Goodall A. H., Naylor A. R. The patients thrombo-embolic response following carotid endarterectomy is related to enhanced platelet sensitivity to ADP. J Vasc Surg, 2003, 38: 1226–31.
  • Payne D. A., Jones C. I., Hayes P. D., Thompson M. M., London N. J. M., Bell P. R. F., Goodall A. H., Naylor A. R. Beneficial effects of Clopidogrel combined with Aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation, 2004, 109: 1476–1481.
  • Payne D. A., Jones C. I., Hayes P. D., Naylor A. R., Goodall A. H. Therapeutic benefit of low dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patient weight. Stroke, 2007, 38: 2464–2469.
  • NICE. Statins for the prevention of cardiovascular events. Technology Appraisal 94. www.nice.org.uk.
  • Perler B. A. The effect of statin medications on peri-operative and long term outcomes following carotid endarterectomy or stenting. Semin Vasc Surg, 2007, 20: 252–258.
  • Leurs L. J., Visser P., Laheij R. J., Buth J., Harris P. L., Blankensteijn J. D. Statin use is associated with reduced all cause mortality after endovascular abdominal aortic aneurysm repair. Vascular, 2006, 14: 1–8.
  • Schanzer A., Hevelone N., Owens C. D., Beckman J. A., Belkin M., Conte M. S. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischaemia. J Vasc Surg, 2008, 47: 774–781.
  • Collard C. D., Body S. C., Shernan S. K., Wang S., Mangano D. T., Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Ischemia Research and Education Foundation (IREF) Investigators. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass surgery. J Thorac Cardiovasc Surg, 2006, 132: 392–400.
  • Kennedy J., Quan H., Buchan A. M., Ghali W. A., Feasby T. E. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke, 2005, 36: 20722076.
  • McGirt M. J., Perler B. A., Brooke B. S., Woodworth G. F., Coon A., Jain S. et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of peri-operative stroke and mortality after carotid endarterectomy. J Vasc Surg, 2005, 42: 829–836.
  • Biccard B. M. A peri-operative statin update for non-cardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial design. Anaesthesia, 2008, 63: 162–171.
  • Naylor A. R. Delay may reduce the procedural risk, but at what price to the patient ? Eur J Vasc Endovasc Surg, 2008, 35: 383–391.
  • Guyton J. R. Benefit versus risk in statin treatment. Am J Cardiol, 2006, 97: 95C-97C.
  • Schouten O., Kertai M. D., Bax J. J., Durazzo A. E. S., Biagini E., Boersma E. et al. Safety of peri-operative statin use in high risk patients undergoing major vascular surgery. Am J Cardiol, 2005, 95: 658–660.
  • Bond R., Narayan S., Rothwell PM., Warlow CP. on behalf of the European Carotid Surgery Trialists’ Collaborative Group. Clinical and radiological risk factors for operative stroke and death in the European Carotid Surgery Trial. Eur J Vasc Endovasc Surg, 2002, 23: 108–116.
  • Naylor A. R., Evans J., Thompson M. M., London N. J. M., Abbott R. J., Cherryman G., Bell P. R. F., Naylor A. R. Seizures after carotid endarterectomy: Hyperperfusion, dysautoregulation or hypertensive encephalopathy ? Eur J Vasc Endovasc Surg, 2003, 26: 39–44.
  • Payne D. A., Jones C. I., Webster S. E., Hayes P. D., Bell P. R. F., Goodall A. H., Naylor A. R. Platelet inhibition by aspirin is diminished in patients during carotid surgery: A transient form of aspirin resistance ? Thromb Haemostas, 2004, 92: 89–96.
  • Webster S. E., Payne D. A., Jones C. I., Hayes P. D., Bell P. R. F., Goodall A. H., Naylor A. R. The anti-platelet effect of Aspirin is Significantly Reduced following Administration of Heparin during Carotid Endarterectomy. J Vasc Surg, 2004, 40: 463–468.
  • McMahon G. S., Webster S. E., Hayes P. D., Jones C. I., Goodall A. H., Naylor A. R. Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy: A randomised trial. Eur J Vasc Endovasc Surg (in press).
  • Gaunt M. E., Smith J., Martin P. J., Ratliff D. A., Bell P. R. F., Naylor A. R. On-table diagnosis of incipient carotid artery thrombosis during carotid endarterectomy using transcranial Doppler sonography. J Vasc Surg, 1994, 20: 104–107.
  • Gaunt M. E., London N. J. M., Smith J., Martin P. J., Bell P. R. F., Naylor A. R. Early diagnosis of post-operative carotid occlusion using transcranial Doppler ultrasound. J Vasc Surg, 1994, 20: 1004–1005.
  • Levi C. R., O’Malley H. M., Fell G. et al. Transcranial Doppler detected cerebral embolism following carotid endarterectomy: High microembolic signal loads predict post-operative cerebral ischaemia. Brain, 1997, 120: 621–629.
  • Cantelmo N. L., Babikian V. L., Samaraweera R. N. et al. Cerebral microembolism and ischaemia changes associated with carotid endarterectomy. J Vasc Surg, 1998, 27: 1024–1030.
  • Spencer M. P. Transcranial Doppler monitoring and causes of stroke from carotid endarterectomy. Stroke, 1997, 28: 685–691.
  • Laman D. M., Wieneke G. H., van Dujin H., van Huffelen A. C. High embolic rate after carotid endarterectomy is associated with early cerebrovascular symptoms, especially in women. J Vasc Surg, 2002, 36: 278–284.
  • Horn J., Naylor A. R., Laman M., Chambers B., Stork J., Schroeder T. V., Yuan-Nielsen M., Dunne V., Ackerstaff R. Identification of patients at risk for ischaemic complications after carotid endarterectomy with TCD monitoring. Eur J Vasc Endovasc Surg, 2005, 30: 270–4.
  • Levi C. R., Stork J. L., Chambers B. R., Abbott A. L., Cameron H. M., Peeters A. et al. Dextran reduces embolic signals after carotid endartectomy. Ann Neurol, 2001, 50: 544–7.
  • Jones C. I., Payne D. A., Hayes P. D., Naylor A. R., Bell P. R., Thompson M. M., Goodall A. H. The antithrombotic effect of Dextran 40 in man is due to enhanced fibrinolysis in vivo. J Vasc Surg, 2008, 48: 655–658.
  • Sharpe R., Walker J., Bown M., Naylor M. B., Evans D. H., Naylor A. R. Identifying the high risk patient with clinically relevant embolisation after carotid endarterectomy. Eur J Vasc Endovasc Surg, 2009, 37: 1–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.